共 50 条
- [31] Patient Protection and Access to Innovative Medicinal Products in the European Union Drug information journal : DIJ / Drug Information Association, 2008, 42 (3): : 281 - 295
- [32] Patient protection and access to innovative medicinal products in the European union DRUG INFORMATION JOURNAL, 2008, 42 (03): : 281 - 295
- [34] Adverse drug reactions in children reported by European consumers from 2007 to 2011 International Journal of Clinical Pharmacy, 2014, 36 : 295 - 302
- [36] Determination of Chemical Composition and In Vitro Dissolution Profiles of Herbal Drug Products Containing Ginkgo biloba Available on the Brazilian Market LATIN AMERICAN JOURNAL OF PHARMACY, 2008, 27 (05): : 674 - 680
- [39] GINKGO BILOBA L. AND THE EFFECT OF ITS FERMENTED PRODUCTS ON PRODUCTION PHYSIOLOGY, BLOOD CHEMISTRY AND HISTOLOGY OF LIVESTOCK SPECIES: A REVIEW APPLIED ECOLOGY AND ENVIRONMENTAL RESEARCH, 2024, 22 (05): : 4563 - 4579
- [40] Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 13